Literature DB >> 1289193

Thrombotic thrombocytopenic purpura developed during ticlopidine therapy.

G Falezza, D Girelli, O Olivieri, G Gandini, R Corrocher, G De Sandre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1289193

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  4 in total

1.  Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality.

Authors:  F L Paradiso-Hardy; C M Angelo; K L Lanctôt; E A Cohen
Journal:  CMAJ       Date:  2000-11-28       Impact factor: 8.262

2.  [Thrombotic thrombocytopenic purpura (Moschkowitz-syndrome) caused by ticlopidine].

Authors:  J M Chemnitz; A Schulz; A Salameh; C Scheid; R Müller; A Draube; V Diehl; D Söhngen
Journal:  Med Klin (Munich)       Date:  2000-02-15

Review 3.  Ticlopidine. A review of its pharmacology, clinical efficacy and tolerability in the prevention of cerebral ischaemia and stroke.

Authors:  S Noble; K L Goa
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

Review 4.  Adverse haematological effects of ticlopidine. Prevention, recognition and management.

Authors:  B B Love; J Biller; M Gent
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.